Clinical Trial Update: Role of Presepsin as a Novel Biomarker in Diagnosis of Neonatal Sepsis

View source ↗

Summary

This clinical trial investigates presepsin as a diagnostic biomarker for neonatal sepsis. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Snippet

Sponsor: Sohag University | Conditions: Neonatal Sepsis | Status: NOT_YET_RECRUITING